期刊文献+

金纳米荧光分子信标在BRCA1 mRNA检测中的应用

Application of Gold-Nanoparticle-Based Fluorescent Molecular Beacons in BRCA1 mRNA Detection
原文传递
导出
摘要 为实时检测活细胞中乳腺癌易感基因1(BRCA1)的信使核糖核酸(mRNA)的表达量,设计并成功制备出一种新型金纳米荧光分子信标。研究了该信标的特异性、灵敏度、稳定性和毒性,并通过激光共聚焦和流式细胞术技术检测了该信标的荧光恢复强度,实现了对人胃癌细胞BGC823和其耐药细胞BGC823/DDP中BRCA1 mRNA表达量的检测。利用逆转录-聚合酶链反应(RT-PCR)技术,验证了该信标用于检测细胞中BRCA1 mRNA表达量的可靠性。结果表明,该信标具有优良特性,能可靠检测出肿瘤细胞中BRCA1 mRNA的表达水平。 In order to detect the expression of messenger ribonucleic acid(mRNA)of the breast cancer susceptibility gene 1(BRCA1))in real time in living cells,a novel gold-nanoparticle-based fluorescent molecular beacon is designed and successfully prepared. The specificity,sensitivity,stability and toxicity of this beacon are investigated,the fluorescence recovery strength of this beacon is detected by the techniques of laser confocal microscopy and flow cytometry,and thus the expression of BRCA1 mRNA in human gastric cancer cell BGC823 and its drug-resistant cell BGC823/DDP is realized.The reverse transcription polymerase chain reaction(RT-PCR)technique is used to verify the reliability of this beacon for detecting the expression of BRCA1 mRNA in cells.The results show that this beacon has excellent characteristics and can be reliably used to detect the expression level of BRCA1 mRNA in tumor cells.
作者 刘若男 李婷婷 周秋梅 顾月清 Liu Ruonan, Li Tingting, Zhou Qiumei, Gu Yueqing(Laboratory of Biomedical Engineering, China Pharmaceutical University, Nanjing, Jiangsu 210009, Chin)
出处 《中国激光》 EI CAS CSCD 北大核心 2018年第2期251-258,共8页 Chinese Journal of Lasers
基金 国家973计划(2015CB755504) 国家自然科学基金(81220108012) 国家重大科研仪器设备研制项目(8172780057)
关键词 医用光学 MRNA检测 分子信标 乳腺癌易感基因1 金纳米颗粒 medical optics mRNA detection molecular beacon breast cancer susceptibility gene 1 gold-nanoparticle
  • 相关文献

参考文献2

二级参考文献9

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部